Featured news in The Life Sciences Report



Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio dMAb(TM) Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies (9/21/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Responds To Deceptive Short Seller Reports (9/20/2017)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Files Lawsuit Against The Capitol Forum (9/21/2017)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx provides Information on Its Interaction With The SEC (9/21/2017)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease (9/19/2017)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
Anticipates Maturing Discussions will Lead to One or More New Partnership Agreements in the Near Term (9/13/2017)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update (9/19/2017)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development (9/20/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Roche (RHHBY) Announces Positive Data on Leukemia Drug (9/19/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx To Host Shareholder Call On September 21, 2017 To Update Progress On Various Strategic Initiatives And Respond To Topics Requested By Shareholders (9/19/2017)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Earnings Review and Free Research Report: Mesoblast Reported Q4 and Full Year FY17 Results (9/20/2017)

view
 


Viveve Medical Inc. (VIVE:NASDAQ)
Viveve to Present at the Ladenburg Thalmann 2017 Healthcare Conference (9/19/2017)

view
 


Resverlogix Corp. (RVX:TSX)
Today's Research Reports on ProMIS Neurosciences, Resverlogix, Spectral Medical and Fennec Pharmaceuticals (9/19/2017)

view
 


RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference (9/19/2017)

view
 

RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
Featured Company News - RXi Pharma's Chief Business Officer, Alexey Eliseev, to Leave the Company (9/19/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA (9/18/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Patent Infringement Lawsuit Updates (9/18/2017)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Files With The FDA To Initiate The Company's Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee (9/19/2017)

view